Back to Search Start Over

Clinical insights from Wolman disease: Evaluating infantile hepatosplenomegaly.

Authors :
Hannah WB
Ryan K
Pendyal S
Burrow TA
Harley SE
Cordell M
McCall CM
Mavis AM
Tan QK
Kishnani PS
Source :
American journal of medical genetics. Part A [Am J Med Genet A] 2022 Nov; Vol. 188 (11), pp. 3364-3368. Date of Electronic Publication: 2022 Aug 16.
Publication Year :
2022

Abstract

There is a broad differential diagnosis of infantile hepatosplenomegaly, with some etiologies being debilitating and treatable. A structured approach to history, examination, and laboratory and radiographic findings is important in diagnosis. Herein, we present a case of Wolman disease presenting as hepatosplenomegaly in an infant. This case details important learning points to help distinguish the diagnosis of Wolman disease from other conditions with overlapping clinical features, such as hemophagocytic lymphohistiocytosis (HLH). The advent of enzyme replacement therapy has dramatically changed the natural history of Wolman disease, and this child showed remarkable improvement with treatment. This child was later found to have extensive adenopathy with retroperitoneal lymph node biopsy demonstrating diffuse infiltration by lipid-laden macrophages, fatty deposits, cholesterol crystals, and calcifications. Similar to the collection of characteristic cells in other lysosomal storage disorders, we postulate that this is characteristic of underlying Wolman disease. We conclude with a summary of learning points from this presentation on infantile hepatosplenomegaly, pertinent to the geneticist, pediatrician, and pediatric subspecialists.<br /> (© 2022 Wiley Periodicals LLC.)

Details

Language :
English
ISSN :
1552-4833
Volume :
188
Issue :
11
Database :
MEDLINE
Journal :
American journal of medical genetics. Part A
Publication Type :
Academic Journal
Accession number :
35972026
Full Text :
https://doi.org/10.1002/ajmg.a.62923